AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Feb 27, 2013

30339_dirs_2013-02-27_ee652540-76a4-43b4-bc75-bafd5b90f49c.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-02-26

Reporting Person: Bedwell Warwick (President, Pharma Pkgs Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-26	Common Stock	M	4729.0000	$42.4400	Acquired	8525.0000	Direct
2013-02-26	Common Stock	M	4281.0000	$40.8500	Acquired	12806.0000	Direct
2013-02-26	Common Stock	M	3153.0000	$36.1000	Acquired	15959.0000	Direct
2013-02-26	Common Stock	F	8936.0000	$60.2100	Disposed	7023.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-26	Stock Option (Right to Buy)	$42.4400	M	4729.0000	Disposed	2022-02-21	Common Stock (4729.0000)	Direct
2013-02-26	Stock Option (Right to Buy)	$40.8500	M	4281.0000	Disposed	2021-02-22	Common Stock (4281.0000)	Direct
2013-02-26	Stock Option (Right to Buy)	$36.1000	M	3153.0000	Disposed	2020-10-22	Common Stock (3153.0000)	Direct